1. FDA decision coming soon on Aimmune's contested peanut allergy drug — Roche's Tecentriq fails in bladder cancer trial — Pfizer launches biosims for Roche's 'big three' cancer drugs in the US — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Lawsuit: Judge bars Ex-Stryker employee from AAOS conference

Discussion in 'Blue Belt Technologies' started by Anonymous, Mar 22, 2013 at 1:07 AM.

  1. Anonymous

    Anonymous Guest

  2. Anonymous

    Anonymous Guest

    They are just h8ing on Blue Belt because they know its a blockbuster. Knees, wrists , ankles spines, skulls and then soft tissue to destroy even Intuitive Surgical. True innovation and no court or corporation can stop true innovation.
     
  3. Anonymous

    Anonymous Guest

    Bruty, is that you? If it is, we missed ya in Chi-town. The deep dish was delicious.
     
  4. Anonymous

    Anonymous Guest

    Rofl. Stryker could have bought BlueBelt for pocket change. Instead, they bought Mako for $1.6 BILLION. Maybe BB can cut a deal with Black & Decker and be on Home Depot shelves in time for Xmas.
     
  5. Anonymous

    Anonymous Guest

    Nothing great about this system. Several surgeons have mentioned the difficulty / impossible managing the posterior resection (told to wing it with a saw) AKA the flexion space to those non literate in orthopedics. This is a Navigation bur prompt up as Robotic for pure marketing purposes